![Ding Ping Zhu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ding Ping Zhu
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Ding Ping Zhu
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
China Pharmaceutical University
13
| College/University | Other Consumer Services | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ding Ping Zhu
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED | Information Technology Services | Director/Board Member | |
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
Yunnan University | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Doctorate Degree | |
HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
University of Toledo (Ohio) | College/University | Doctorate Degree | |
JIANGSU LIANHUAN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
HANGZHOU TIANMUSHAN PHARMACEUTICAL ENTERPRISE CO.,LTD | Pharmaceuticals: Major | Director/Board Member | |
PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD | Biotechnology | Director/Board Member | |
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Nanjing University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Jiangsu Simcere Pharmaceutical Co., Ltd.
![]() Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
Tsinghua University | College/University | Masters Business Admin | |
Shanghai Jiao Tong University | College/University | Undergraduate Degree | |
Zhengzhou University | College/University | Undergraduate Degree | |
Shanghai Fosun Pharmaceutical Co. Ltd.
![]() Shanghai Fosun Pharmaceutical Co. Ltd. Medical DistributorsDistribution Services Shanghai Fosun Pharmaceutical Co. Ltd. distributes pharmaceutical products. The firm’s service area include everyday necessities, sanitization products, cotton knitwear, fitness equipment, chemical products and raw materials, glass apparatus, pet products, Chinese patent drugs, Chinese herbal pieces, antibiotic, biological products, narcotic drugs, and medicinal toxic. The company is headquartered in Shanghai, China. | Medical Distributors | Corporate Officer/Principal | |
Shenyang Pharmaceutical University | College/University | Doctorate Degree | |
Roche (China) Co. Ltd. | Corporate Officer/Principal | ||
YIXINTANG PHARMACEUTICAL GROUP CO., LTD. | Drugstore Chains | Director/Board Member | |
PENYAO ENVIRONMENTAL PROTECTION CO., LTD. | Industrial Machinery | Director/Board Member | |
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
Nanjing Normal University | College/University | Graduate Degree | |
Nanjing Medical University | College/University | Corporate Officer/Principal | |
Chinese Pharmaceutical Association | Director/Board Member | ||
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Pharmaceuticals: Major | Director/Board Member | |
NANJING HICIN PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
SHANGHAI RENDU BIOTECHNOLOGY CO., LTD. | Medical Specialties | Director/Board Member | |
GETEIN BIOTECH, INC | Biotechnology | Director/Board Member | |
Beijing NeoTrident Technology Co., Ltd.
![]() Beijing NeoTrident Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing NeoTrident Technology Co., Ltd. engages in the research and development of scientific lifecycle management software. Its products include science and technology innovation information, and computational simulation and data modeling platforms. The company was founded on February 29, 2000 and is headquartered in Beijing, China. | Packaged Software | Director/Board Member | |
Abiochem Biotechnology Co., Ltd.
![]() Abiochem Biotechnology Co., Ltd. BiotechnologyHealth Technology Abiochem Biotechnology Co., Ltd. engages in the development of synthetic biological methods, and biological manufacturing and the application of biological technologies in mass production. The company was founded on April 17, 2015 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
![]() Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hua Medicine (Shanghai) Co., Ltd.
![]() Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | Biotechnology | Corporate Officer/Principal | |
BSM CHEMICAL CO.,LTD. | Chemicals: Agricultural | Director/Board Member | |
Zhejiang Youquan Care Products Technology Co., Ltd.
![]() Zhejiang Youquan Care Products Technology Co., Ltd. Household/Personal CareConsumer Non-Durables Zhejiang Youquan Care Products Technology Co., Ltd. mainly engages in the research, development, production, and sale of non-woven materials and care products. Its key products include spunlace nonwoven materials, spunbond nonwoven materials, hot air nonwoven materials, wet and dry towels, as well as diapers. The company was founded by Hua Rong Yan on July 6, 2012 and is headquartered in Huzhou, China. | Household/Personal Care | Director/Board Member | |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | Pharmaceuticals: Major | Director/Board Member | |
ALPHAMAB ONCOLOGY | Biotechnology | Chief Tech/Sci/R&D Officer | |
I-MAB | Pharmaceuticals: Major | Director/Board Member | |
FibroGen (China) Medical Technology Development Co. Ltd.
![]() FibroGen (China) Medical Technology Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of FibroGen, Inc., FibroGen (China) Medical Technology Development Co., Ltd. is a biomedical technology company based in Beijing, China. FibroGen () is dedicated to developing new mechanisms of action or "best-in-class" innovative drugs and medical devices to meet the unmet clinical needs of Chinese patients. The Chinese company also provides a platform to report adverse events related to FibroGen roxadustat products. The company was founded in 2011. Christine Chung L. has been the CEO of the company since 2019. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kente Catalysts Inc.
![]() Kente Catalysts Inc. Chemicals: SpecialtyProcess Industries Kente Catalysts Inc. principally engages in the research, development, production, and sale of quaternary ammonium compounds. Its products include quaternary ammonium salt, quaternary ammonium hydroxide, quaternary phosphonium salt, and crown ether. The company was founded on July 14, 2009 and is headquartered in Taizhou, China. | Chemicals: Specialty | Director/Board Member | |
NANJING VAZYME BIOTECH CO.,LTD | Biotechnology | Director/Board Member | |
Joinstar Biomedical Technology Co., Ltd.
![]() Joinstar Biomedical Technology Co., Ltd. Medical SpecialtiesHealth Technology Joinstar Biomedical Technology Co., Ltd. principally engages in the research, development, production, and sale of in vitro diagnostic products. Its products include diagnostic instruments, reagents, and biological raw materials. The company was founded on December 16, 2010 and is headquartered in Hangzhou, China. | Medical Specialties | Director/Board Member | |
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Suzhou Sepax Technologies Co., Ltd.
![]() Suzhou Sepax Technologies Co., Ltd. Medical SpecialtiesHealth Technology Suzhou Sepax Technologies Co., Ltd. engages in the research, development, production, and sale of liquid chromatography materials. Its business areas include Analytical chromatography and Industrial purification. It offers size exclusion columns, ion exchange columns, affinity columns, analytical grade packing, affinity chromatography media, silica-based packing, prepacked columns, and related accessories. The company was founded by Xue Ying Huang on March 16, 2009 and is headquartered in Suzhou, China. | Medical Specialties | Director/Board Member | |
JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD | Biotechnology | Director/Board Member | |
Shanghai Innostar Biotechnology Co., Ltd.
![]() Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
YSB INC. | Packaged Software | Director/Board Member |
Statistik
International
China | 44 |
Vereinigte Staaten | 5 |
Hong Kong | 2 |
Cayman Islands | 2 |
Sektoral
Health Technology | 27 |
Consumer Services | 12 |
Technology Services | 4 |
Process Industries | 3 |
Distribution Services | 2 |
Operativ
Director/Board Member | 32 |
Undergraduate Degree | 13 |
Corporate Officer/Principal | 12 |
Independent Dir/Board Member | 12 |
Graduate Degree | 8 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Hai Bo Qian | 12 |
Rong Shao | 12 |
Miao Chen | 10 |
Liang Kong | 6 |
Zuo Jun Dong | 5 |
Zheng Hua Ren | 5 |
Si Tang Duan | 4 |
Ben Niu | 3 |
Liang Ming Shen | 2 |
Jing Yang | 2 |
Jing Sun | 2 |
Mingsheng Feng | 2 |
Hai Ye | 2 |
- Börse
- Insiders
- Ding Ping Zhu
- Unternehmensverbindungen